A phase IV, prospective, non-interventional, multicenter study evaluating the efficacy and safety of tolvaptan in patients with heart failure

Trial Profile

A phase IV, prospective, non-interventional, multicenter study evaluating the efficacy and safety of tolvaptan in patients with heart failure

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 15 Nov 2017

At a glance

  • Drugs Tolvaptan (Primary)
  • Indications Heart failure
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms SMILE
  • Most Recent Events

    • 15 Nov 2017 Results of prevention of hypernatraemia after tolvaptan treeatment by using data from post-marketing study (n=3350) presented at the 90th Annual Scientific Sessions of the American Heart Association
    • 05 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top